Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2015 (2015), Article ID 671232, 5 pages
http://dx.doi.org/10.1155/2015/671232
Research Article

Clinical Experience of Patients Referred to a Multidisciplinary Cardiac Oncology Clinic: An Observational Study

1The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, Canada K1H 8L6
2Division of Cardiology, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada K1H 8L6
3Department of Pharmacy, The Ottawa Hospital, Ottawa, ON, Canada K1H 8L6

Received 13 October 2014; Accepted 15 December 2014

Academic Editor: Daniel Lenihan

Copyright © 2015 Jeffrey Sulpher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Herrmann, A. Lerman, N. P. Sandhu, H. R. Villarraga, S. L. Mulyagh, and M. Kohli, “Evaluation and management of patients with heart disease and cancer: cardio-oncology,” Mayo Clinical Proceedings, vol. 89, no. 9, pp. 1287–1306, 2014. View at Google Scholar
  2. I. N. Daher, T. R. Daigle, N. Bhatia, and J.-B. Durand, “The prevention of cardiovascular disease in cancer survivors,” Texas Heart Institute Journal, vol. 39, no. 2, pp. 190–198, 2012. View at Google Scholar · View at Scopus
  3. C. L. Chen and R. Steingart, “Cardiac disease and heart failure in cancer patients: is our training adequate to provide optimal care?” Heart Failure Clinics, vol. 7, no. 3, pp. 357–362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Ferrara, H.-P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nature Medicine, vol. 9, no. 6, pp. 669–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Hurwitz, L. Fehrenbacher, W. Novotny et al., “Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer,” The New England Journal of Medicine, vol. 350, no. 23, pp. 2335–2342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Maurea, C. Coppola, G. Ragone et al., “Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy,” Journal of Cardiovascular Medicine, vol. 11, no. 12, pp. 861–868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. T. M. Suter and M. S. Ewer, “Cancer drugs and the heart: importance and management,” European Heart Journal, vol. 34, no. 15, pp. 1102–1111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. G. di Lorenzo, R. Autorino, G. Bruni et al., “Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis,” Annals of Oncology, vol. 20, no. 9, pp. 1535–1542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. J. Richards, Y. Je, F. A. B. Schutz et al., “Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib,” Journal of Clinical Oncology, vol. 29, no. 25, pp. 3450–3456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Force, D. S. Krause, and R. A. Van Etten, “Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition,” Nature Reviews Cancer, vol. 7, no. 5, pp. 332–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Dent, S. Hopkins, N. Graham et al., “The experience of a multidisciplinary clinic in the management of early-stage breast cancer patients receiving trastuzumab therapy: an observational study,” Cardiology Research and Practice, vol. 2012, Article ID 135819, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Jones, M. Barlow, P. J. Barrett-Lee et al., “Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring,” British Journal of Cancer, vol. 100, no. 5, pp. 684–692, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Shelburne, B. Adhikari, J. Brell et al., “Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities,” Journal of the National Cancer Institute, vol. 106, no. 9, Article ID dju232, 2014. View at Publisher · View at Google Scholar